156 related articles for article (PubMed ID: 12648072)
1. Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia.
Hsi ED; Kopecky KJ; Appelbaum FR; Boldt D; Frey T; Loftus M; Hussein MA
Br J Haematol; 2003 Mar; 120(6):1017-25. PubMed ID: 12648072
[TBL] [Abstract][Full Text] [Related]
2. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Dignum H; Taylor PR; Dickinson AM; Saunders PW; Proctor SJ; Summerfield GP
Br J Haematol; 2002 Sep; 118(3):755-61. PubMed ID: 12181042
[TBL] [Abstract][Full Text] [Related]
3. Quantification of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL): a comparison between antibody binding capacity (ABC) and relative median fluorescence (RMF).
Dignum HM; Summerfield GP; Proctor SJ; Mainou-Fowler T
Leuk Lymphoma; 2004 Jun; 45(6):1167-73. PubMed ID: 15359996
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL).
Mainou-Fowler T; Dignum HM; Proctor SJ; Summerfield GP
Leuk Lymphoma; 2004 Mar; 45(3):455-62. PubMed ID: 15160906
[TBL] [Abstract][Full Text] [Related]
5. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.
Boonstra JG; von't Veer MB; Gratama JW
J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702
[TBL] [Abstract][Full Text] [Related]
6. Correlation between cell size and CD38 expression in chronic lymphocytic leukaemia.
Manocha S; Matrai Z; Osthoff M; Carter A; Pettitt AR
Leuk Lymphoma; 2003 May; 44(5):797-800. PubMed ID: 12802916
[TBL] [Abstract][Full Text] [Related]
7. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
[TBL] [Abstract][Full Text] [Related]
8. Relative importance of CD38 expression over myeloid-associated markers expression in predicting the clinical course of B-CLL patients.
Chang CC; Liu CZ; Cleveland RP
Leuk Lymphoma; 2003 Jun; 44(6):977-82. PubMed ID: 12854897
[TBL] [Abstract][Full Text] [Related]
9. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
Chevallier P; Penther D; Avet-Loiseau H; Robillard N; Ifrah N; Mahé B; Hamidou M; Maisonneuve H; Moreau P; Jardel H; Harousseau JL; Bataille R; Garand R
Br J Haematol; 2002 Jan; 116(1):142-50. PubMed ID: 11841407
[TBL] [Abstract][Full Text] [Related]
10. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
[TBL] [Abstract][Full Text] [Related]
11. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
[TBL] [Abstract][Full Text] [Related]
13. Bimodal cell populations are common in chronic lymphocytic leukemia but do not impact overall survival.
Cocco AE; Osei ES; Thut DM; Edinger AK; Powers JJ; Fu P; Meyerson HJ
Am J Clin Pathol; 2005 Jun; 123(6):818-25. PubMed ID: 15899771
[TBL] [Abstract][Full Text] [Related]
14. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.
Ghia P; Guida G; Stella S; Gottardi D; Geuna M; Strola G; Scielzo C; Caligaris-Cappio F
Blood; 2003 Feb; 101(4):1262-9. PubMed ID: 12406914
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
Gentile M; Mauro FR; Calabrese E; De Propris MS; Giammartini E; Mancini F; Milani ML; Guarini A; Foà R
Br J Haematol; 2005 Aug; 130(4):549-57. PubMed ID: 16098069
[TBL] [Abstract][Full Text] [Related]
17. CD38 as a prognostic marker in CLL.
Matrai Z
Hematology; 2005 Feb; 10(1):39-46. PubMed ID: 16019444
[TBL] [Abstract][Full Text] [Related]
18. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
Ibrahim S; Keating M; Do KA; O'Brien S; Huh YO; Jilani I; Lerner S; Kantarjian HM; Albitar M
Blood; 2001 Jul; 98(1):181-6. PubMed ID: 11418478
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
[TBL] [Abstract][Full Text] [Related]
20. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U
Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
